Cocrystal Pharma, Inc.

Trading of Opko Health Inc. shares on Nasdaq was halted by the exchange on Sept. 7 and the company said on Sept. 11 that trading will not resume until the company provides a satisfactory response to

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

Baloxavir marboxil, the first in a new class of antiviral treatments, has been granted priority review by the US FDA. Unlike other currently available antiviral therapies, baloxavir marboxil is design

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in